“This year has been a testament to our resolve to operate responsibly while fostering resilience in the face of evolving global challenges. We have made significant strides in advancing our sustainability goals. Our initiatives span energy efficiency, water management, waste management, fostering a diverse and inclusive workplace, and community development.”
Nandini Piramal
Chairperson
“We strongly partner and practice sustainable procurement and operations promoting trust, transparency, human rights, ethical code of conduct among our value chain governed by our Sustainable Procurement Policy.”
Peter DeYoung
CEO, Global Pharma
Being a pharmaceutical company, we are highly committed to conserving the environment through efficient energy and water management, emission reduction, and sustainable waste and effluents management. At Piramal Pharma Limited, we have a robust system to ensure regulatory and environmental compliances. Energy management is one of Piramal Pharma Limited’s primary focus areas because of its direct influence on emissions and costs associated with our operations.
*During the reporting year, absolute energy consumption increased on YoY basis. This increase is attributed to increase in production and addition of new sites.
#Bio-briquette is a sustainable substitute over fossil fuel with negligible SOx emissions and deployment of which support environment friendly use of agricultural waste. Further, in comparison to fossil fuel (coal), bio-briquettes produce lower value chain GHG emissions as biomass is already a part of carbon cycle.
Note: Numbers of FY21 have been updated due to correction in calorific values.
At our manufacturing facilities, GHG emissions are mainly from the usage of fossil fuels and consumption of grid electricity. Our direct emissions include emissions from diesel, coal, natural gas, and furnace oil within the boundaries of Piramal Pharma Limited, while our indirect emissions include emissions from purchased grid electricity and purchased steam.
All emission factors for direct energy have been used as per the IPCC guidelines for GHG inventories (2006), while the emission factor for indirect energy (i.e., purchased electricity) is taken from the Indian Central Electricity Authority’s (CEA) Baseline Carbon Dioxide Emission Database, DEFRAO (UK) and United States Environmental Protection Agency (EPA).
At Piramal Pharma Limited, we monitor air emissions at all our facilities and ensure they are within the permissible limit. Air emissions at all our facilities are monitored closely with the help of stack monitoring system and ambient air quality monitoring system.
The pharmaceutical manufacturing uses large volumes of water for production and industrial processes. Due to climate related events, growing population, widespread urbanisation and pollution, water availability is becoming challenging and expensive. We are exploring.
Due to the nature of our business, a substantial amount of hazardous waste is generated as a result of our operations. A significant portion of the waste generated in the pharma industry is classified as hazardous and requires safe handling. Piramal Pharma Limited ensures that the hazardous waste generated by our operations is safely handled, temporarily stored and disposed of in an environmentally responsible manner, in line with relevant regulations. We comply with existing statutory requirements for the handling and disposal of hazardous waste. Solvent recovery systems installed at API/chemical sites enable the recovery of solvents for reuse. Sites also engaged external agency for recovery of reused recoverable solvents.
We, at Piramal, undertook various initiatives to reduce our environmental footprint. These initiatives are driven across the sites, facilitated by the Operational Excellence team. Guided by the Company’s vision and core values, the Operational Excellence model directs our focus in making the manufacturing process robust and efficient, while eliminating all the hidden wastes in the processes.
The tools and techniques of Lean and Six Sigma philosophy are very effective in improving the imperatives like product yield, capacity, OTIF (On Time in Full), cost of poor quality, energy conservation, waste reduction and reduction in use of fresh solvent and catalysts. Some of the initiatives that helped Piramal Pharma Limited to reduce carbon footprint are given below as an example.